India: Strides Arcolab Launches Generic Version of Hepatitis C Drug

New Delhi: Strides Arcolab on announced launch of the generic version of Hepatitis C drug 'Sofosbuvir' under the brand name 'Virso'.

The product will be available to Indian patients shortly, the Bangalore-based company said in a statement.

"In September 2014, Strides entered into a licensing agreement with Gilead Sciences Inc to bring Hepatitis C cure to 91 developing countries," Strides Arcolab said in a statement.


Labels: , ,